ORKA Oruka Therapeutics, Inc.
$95.81▲ +6.07%
Healthcare
Other
After hours
$96.50▲ +0.72%
Oct 27, 4:16 PM ET
Volume 1.21M
Avg Volume (10D) 939.9K
Key Metrics & Fundamentals
Market Cap
$6.34B
P/E Ratio
–
Div Yield
0.00%
52W Range
25.23 - 115.52
% vs 50 MA
7.37%
% vs 200 MA
40.37%
RSI-14
66.2
MACD Histogram
+2.2700
Beta (1Y vs SPY)
1.43
Free Cash Flow
-$33.15M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$50.06M
COGS
–
Operating Exp
$50.11M
Operating Income
-$50.11M
EBIT
-$50.11M
Pretax Income
-$41.21M
Net Income
-$41.21M
EPS (Diluted)
-0.55
Price & Volume History
Loading chart…
Recent News
Oruka Therapeutics Stock Gets A Lift From Psoriasis Trial Results
Simply Wall St. · Oct 27, 2026 3:06 AM ET
Oruka’s ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis Study
MarketBeat · Oct 26, 2026 11:02 PM ET
Oruka Therapeutics Soars 12% as Psoriasis Drug Clears Skin in 61% of High-Dose Patients: “A Paradigm Shift”
TIKR · Oct 26, 2026 1:45 PM ET
Oruka’s Psoriasis Treatment Could Generate $7B In Peak Sales, Says Guggenheim – ORKA Stock Heads For Best Day In Over 4 Months
Stocktwits · Oct 26, 2026 12:07 PM ET
Oruka Therapeutics Psoriasis Drug Clears Skin in 61% of Patients in Phase 2 Trial
MT Newswires · Oct 26, 2026 7:58 AM ET
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
GlobeNewswire · Oct 26, 2026 7:00 AM ET
Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
Stocktwits · Oct 25, 2026 10:28 PM ET
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
GlobeNewswire · Oct 25, 2026 12:00 PM ET
How Halozyme, Up Nearly 90% This Year, Is Rivaling Merck And Hitting New Highs
Investor's Business Daily · Oct 23, 2026 4:11 PM ET
Oruka Therapeutics Insider Sold Shares Worth $706,735, According to a Recent SEC Filing
MT Newswires · Oct 21, 2026 4:03 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ORKA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.